Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT).

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2006-07-034272PMID 17110459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

  2005cited by this paper
• Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.

  2003cited by this paper
• Results and follow‐up of a phase III randomized study of recombinant human‐granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia

  2002cited by this paper
• Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy

  2001cited by this paper
• Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group.

  2001cited by this paper
• Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Tra

  2000cited by this paper
• Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.

  2000cited by this paper
• What Is the Definition of Cure for Aplastic Anemia?

  2000cited by this paper
• Late clonal diseases of treated aplastic anemia.

  2000cited by this paper
• Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.

  2000cited by this paper
• Long‐term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation

  2000cited by this paper
• Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia

  2000cited by this paper
• Current Results of Bone Marrow Transplantation in Patients with Acquired Severe Aplastic Anemia

  2000cited by this paper
• Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.

  2000cited by this paper
• Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.

  1997cited by this paper
• Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia.

  1995cited by this paper
• Antilymphocyte globulin, cyclosporin, and granulocyte colony- stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party

  1995cited by this paper
• Haemopoietic growth factors in aplastic anaemia: a cautionary note

  1994cited by this paper
• Haemopoietic growth factors in aplastic anaemia: a cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia.

  1994cited by this paper
• Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

  1993cited by this paper
• Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT * SAA Working Party

  1988cited by this paper

• First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants

  2024cites this paper
• Clinical and genetic profiles and outcomes of allogeneic haematopoietic stem cell transplantation in secondary myelodysplastic syndrome following aplastic anaemia

  2024cites this paper
• Autoimmune pathogenesis, immunosuppressive therapy and pharmacological mechanism in aplastic anemia.

  2023cites this paper
• Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia

  2022cites this paper
• Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe

  2022cites this paper
• Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow

  2022cites this paper
• Profile and Predictors of Infection Following Anti-thymocyte Globulin or Anti-lymphocyte Globulin with Cyclosporine in Aplastic Anemia

  2022cites this paper
• Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

  2022cites this paper
• New Trends of Nontransplant therapy for Acquired Aplastic Anemia.

  2022cites this paper
• Telomere biology disorders

  2021cites this paper
• What Pediatricians Need to Know About Acquired Aplastic Anemia

  2020cites this paper
• Amelioration of cyclophosphamide-induced myelosuppression during treatment to rats with breast cancer through low-intensity pulsed ultrasound

  2020cites this paper
• Bone Marrow Failure

  2020cites this paper
• Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.

  2020cites this paper
• Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

  2019cites this paper
• Acquired centromeric heteromorphism of chromosome 7 yields discordant results between fluorescent in situ hybridization and karyotype analysis in a child with severe congenital neutropenia

  2019cites this paper
• Aplastic Anemia-Diagnostics and Therapy of Acquired Aplastic Anemia

  2018cites this paper
• A brief, but comprehensive, guide to clonal evolution in aplastic anemia.

  2018influential citation
• Inherited Neutropenias and Their Insights into Cellular and Developmental Biology

  2018cites this paper
• Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length

  2018cites this paper
• Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment

  2018cites this paper
• The effects of IL‐1&bgr;, IL‐8, G‐CSF and TNF‐&agr; as molecular adjuvant on the immune response to an E. tarda subunit vaccine in flounder (Paralichthys olivaceus)

  2018cites this paper
• Supportive Care in Aplastic Anemia

  2017cites this paper
• Acquired Overlap Bone Marrow Failure Disorders

  2017cites this paper
• Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia

  2017cites this paper
• Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes—The MD Anderson Cancer Center experience

  2017cites this paper
• Hematological Disorders in Children

  2017influential citation
• Hematopoietic cell transplantation for aplastic anemia

  2017cites this paper
• Rare Bone Marrow Failure Conditions

  2017cites this paper
• Childhood Aplastic Anemia

  2017cites this paper
• Management of Acquired Aplastic Anemia in Children

  2017cites this paper
• Approach to Aplastic Anemia- An Overview and Practical Approach

  2016cites this paper
• Am80‐GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia‐associated infection and mortality

  2016cites this paper
• Hematopoietic stem cell transplantation for acquired aplastic anemia

  2016cites this paper
• Recommendations from the society for diagnosis and therapy of haematological and oncological diseases Guideline Aplastic Anemia-Diagnos tics and Therapy of Acquired Aplastic Anemia

  2016cites this paper
• 获得性再生障碍性贫血克隆性进展为骨髓增生异常综合征/急性髓系白血病：19例临床分析及文献复习

  2015cites this paper
• Immunosuppressive Therapy for Aplastic Anaemia.

  2015cites this paper
• 重组人血小板生成素对重型再生障碍性贫血免疫抑制治疗近期疗效的影响

  2015cites this paper
• The diagnosis and treatment of aplastic anemia: a review

  2015cites this paper
• A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies

  2015cites this paper
• [Acquired aplastic anemia developing myelodysplastic syndrome/acute myeloid leukemia: clinical analysis of nineteen patients and literatures review].

  2015cites this paper
• Immunosuppressive Therapy in Patients with Aplastic Anemia: A Single-Center Retrospective Study

  2015cites this paper
• Acute promyelocytic leukemia transformation in a patient with aplastic anemia: a case report with literature review.

  2015cites this paper
• Concurrent Epstein-Barr virus associated NK/T cell lymphoma after immunosuppressive therapy for aplastic anemia: report of a case and review of literature.

  2015cites this paper
• Immunosuppressive therapy for transplant-ineligible aplastic anemia patients

  2015cites this paper
• First-line immunosuppressive treatment in children with aplastic anemia: rabbit antithymocyte globulin.

  2015cites this paper
• Respiratory Virology and Immunogenicity

  2015cites this paper
• Aplastic Anemia - Diagnos tics and Therapy of Acquired Aplastic Anemia

  2015cites this paper
• Traitement de l’aplasie médullaire idiopathique en 2015

  2015cites this paper
• Original Article Effect of Tianshengyuan-1 (TSY-1) on telomerase activity and hematopoietic recovery - in vitro, ex vivo, and in vivo studies

  2014cites this paper
• SHORT TITLE: Genistein limits DNA Damage

  2014cites this paper
• Side Effects of Cytokines Approved for Therapy

  2014cites this paper
• Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia.

  2014cites this paper
• Aplastic Anemia in Adolescents and Young Adults

  2014cites this paper
• Effect of Tianshengyuan-1 (TSY-1) on telomerase activity and hematopoietic recovery - in vitro, ex vivo, and in vivo studies.

  2014cites this paper
• Genistein Protects Hematopoietic Stem Cells against G-CSF–Induced DNA Damage

  2014cites this paper
• Severe aplastic anemia preceding acute monocytic leukemia in an adult with acquired trisomy 21: A case report

  2013influential citation
• Acquired aplastic anemia in children.

  2013cites this paper
• Hematopoietic stem cell donation

  2013cites this paper
• Epidemiology of congenital neutropenia.

  2013cites this paper
• Supportive care in severe and very severe aplastic anemia

  2013cites this paper
• Recommandations pour la prise en charge diagnostique et thérapeutique des aplasies médullaires acquises de l’enfant

  2013cites this paper
• Hematopoietic Growth Factors in the Supportive Care and Treatment of Patients with Hematologic Neoplasms

  2013cites this paper
• Front-line immunosuppressive treatment of acquired aplastic anemia

  2013cites this paper
• Clinical outcomes after peripheral blood stem cell donation by related donors: a Dutch single‐center cohort study

  2013cites this paper
• Leukemic transformation in patients with myelodysplastic syndromes after treatment with granulocyte colony-stimulating factor

  2012cites this paper
• Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?

  2012cites this paper
• Survival after immunosuppressive therapy in children with aplastic anemia

  2012cites this paper
• How I treat acquired aplastic anemia.

  2012cites this paper
• Eltrombopag and improved hematopoiesis in refractory aplastic anemia.

  2012cites this paper
• How I manage aplastic anaemia in children

  2012cites this paper
• Effects of granulocyte–colony‐stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors

  2012cites this paper
• Genistein Protects Hematopoietic Stem Cells Against G-CSF Induced DNA Damage

  2012cites this paper
• Monosomy 7 in donor cell-derived leukemia after bone marrow transplantation for severe aplastic anemia: Report of a new case and review of the literature

  2012influential citation
• A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.

  2011influential citation
• The bone marrow compartment is modified in the absence of galectin-3

  2011cites this paper
• Increased requirement for platelet transfusions concurrent with enhanced bleeding during romiplostim treatment in a patient with thrombocytopenia due to bone marrow failure

  2011cites this paper
• Immunosuppressive Therapy Without Hematopoietic Growth Factor Exposure in Pediatric Acquired Aplastic Anemia

  2011cites this paper
• Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience

  2011influential citation
• Can G-CSF cause leukemia in hematopoietic stem cell donors?

  2011cites this paper
• Clinical management of aplastic anemia

  2011cites this paper
• FISHing for aneuploidy in HSCT donors.

  2011cites this paper
• Congenital neutropenia: diagnosis, molecular bases and patient management

  2011cites this paper
• Immunosuppressive therapies in the management of immune‐mediated marrow failures in adults: where we stand and where we are going

  2011cites this paper
• 13. Acquired Aplastic Anaemia

  2010cites this paper
• Clonal Bone Marrow Failure Overlap Syndromes

  2010cites this paper
• Drugs that act on the immune system

  2010cites this paper
• Aplastic anemia: pathophysiology and treatment.

  2010cites this paper
• Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation.

  2010cites this paper
• G-CSF and its receptor in myeloid malignancy.

  2010cites this paper
• Donor-derived second hematologic malignancies after cord blood transplantation.

  2010cites this paper
• APLASTIC ANEMIA : ACQUIRED AND INHERITED

  2010cites this paper
• Guidelines for the diagnosis and management of aplastic anaemia

  2009influential citation
• Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.

  2009cites this paper
• Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice

  2009cites this paper
• Diagnosis a nd Treatment of Acq uired Aplastic Anemia

  2009cites this paper
• Aplastica Anemia And Viral Hepatitis

  2009cites this paper
• Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis

  2009cites this paper
• Acquired aplastic anemia in childhood.

  2009cites this paper
• Diagnosis and treatment of acquired aplastic anemia.

  2009cites this paper